Screener
Organogenesis Holdings Inc. ORGO Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
FAQ
- What is Organogenesis Holdings Inc.'s accounts payable?
- Organogenesis Holdings Inc. (ORGO) reported accounts payable of $29.29M in Q2 2026.
- How has Organogenesis Holdings Inc.'s accounts payable changed year-over-year?
- Organogenesis Holdings Inc.'s accounts payable decreased by 1.5% year-over-year, from $29.72M to $29.29M.
- What is the long-term trend for Organogenesis Holdings Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s accounts payable has grown at a 6.4% compound annual growth rate (CAGR), from $23.38M to $31.95M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Organogenesis Holdings Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude